RT Journal Article
SR Electronic
T1 Multisystem Inflammatory Syndrome in Children Managed in the Outpatient Setting: An EHR-based cohort study from the RECOVER program
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.25.22279225
DO 10.1101/2022.08.25.22279225
A1 Jhaveri, Ravi
A1 Webb, Ryan
A1 Razzaghi, Hanieh
A1 Schuchard, Julia
A1 Mejias, Asuncion
A1 Bennett, Tellen D.
A1 Jone, Pei-Ni
A1 Thacker, Deepika
A1 Schulert, Grant S.
A1 Rogerson, Colin
A1 Cogen, Jonathan D.
A1 Bailey, L. Charles
A1 Forrest, Christopher B.
A1 Lee, Grace M.
A1 Rao, Suchitra
A1 ,
YR 2022
UL http://medrxiv.org/content/early/2022/08/25/2022.08.25.22279225.abstract
AB Using electronic health record data combined with primary chart review, we identified 7 children across 8 pediatric medical centers with a diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C) who were managed as outpatients. These findings should prompt a discussion about modifying the case definition to allow for such a possibility.Competing Interest StatementDr. Jhaveri is a consultant for AstraZeneca, Seqirus and Dynavax, and receives an editorial stipend from Elsevier. Dr. Mejias reports funding from Janssen, Merck for research support, and Janssen, Merck and Sanofi-Pasteur for Advisory Board participation; Dr. Schulert reports consulting fees from Novartis and SOBI; Dr. Rao reports prior grant support from GSK and Biofire and is a consultant for Seqirus.Funding StatementThis research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Children's Hospital of Philadelphia's institutional review board designated this study as not human subjects research and waived the need for consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.